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E7 that provides immunity to cells producing colicin E7) folds via a three-
state mechanism involving an on-pathway intermediate. This kinetic
intermediate contains three of four native helices that are oriented in a
non-native manner so as to minimise exposed hydrophobic surface area at
this point in folding. The short (6-residue) helix III has been shown to be
unstructured in the intermediate ensemble and does not dock onto the
developing hydrophobic core until after the rate-limiting transition state has
been traversed. After helix III has docked, it adopts an α-helical secondary
structure, and the side chains of residues within this region provide contacts
that are crucial to native-state stability. In order to probe further the role of
helix III in the folding mechanism of Im7, we created a variant that contains
an eight-amino-acid polyalanine-like helix stabilised by a Glu-Arg salt
bridge and an Asn-Pro-Gly capping motif, juxtaposed C-terminal to the
natural 6-residue helix III. The effect of this insertion on the structure of the
native protein and its folding mechanism were studied using NMR and ϕ-
value analysis, respectively. The results reveal a robust native structure that
is not perturbed by the presence of the extended helix III. Mutational
analysis performed to probe the folding mechanism of the redesigned
protein revealed a conserved mechanism involving the canonical three-
helical intermediate. The results suggest that folding via a three-helical
species stabilised by both native and non-native interactions is an essential
feature of Im7 folding, independent of the helical propensity of helix III.Edited by C. R. Matthews
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Previous studies have shown that the small four-
helical protein Im7 (an inhibitor protein for colicin
E7 that provides immunity to cells producing colicin
E7; Fig. 1a) folds via an unusually rugged folding
landscape involving the population of an on-
pathway hyperfluorescent intermediate.1,2 This spe-
cies contains a core of hydrophobic residues that
is ∼20% expanded compared with the native state
(Fig. 1b) and is stabilised by both native and non-
native interactions.1–4 The intermediate ensemble
lacks a structured helix III, but contains helices I, II
and IV, which are oriented in a non-native manner
so as to minimise the exposed hydrophobic surface
Table 1. Length and predicted average helical propensity
for Im7 helices I, II, III and IV and the newly designed
helix III of Im7H3M3 using the prediction algorithm
AGADIR12
Number of
residues in helix
Percentage
helicity
Measured
percentage helicity
Helix I 13 7.8 14.1
Helix II 14 1.5 9.8
Helix III 6 0.2 0
Helix IV 14 3.1 11.2
Im7H3M3 13 14 16
Peptides corresponding to helices I, II, III and IV were cons-
tructed, and their α-helical content was determined using far-UV
CD at 10 °C in 50 mM sodium phosphate (pH 7.0). The measured
percent helicity for each peptide is also shown.
Fig. 1. (a) Structure of wild-type Im7, drawn from the coordinates of 1AYI.10 Helices are coloured as follows: helix I,
blue; helix II, red; helix III, green; helix IV, yellow. The figure was drawn using Chimera.34 (b) Cartoon representation of
the foldingmechanism of Im7. The on-pathway intermediate forms on the sub-millisecond timescale. How helices I, II and
IV dock in the intermediate and transition state ensembles is shown schematically but is based on restrained molecular
dynamics simulations of these species using Φ-values or hydrogen exchange protection factors as restraints.1,43 The
helical structure in the unfolded state in the absence of denaturant is not known, although it is expected to be low, as
predicted using AGADIR.12
1075Helix Redesign in Im7 Foldingarea that would result from a native-like helical
organisation in the absence of helix III. The low
ϕ-values for point mutations in the sequence that
forms the native helix III in both the intermediate-
state ensemble and the subsequent rate-limiting
transition-state ensemble suggest that helix III only
docks onto the developing protein core subsequent
to crossing the rate-limiting transition-state barrier
as the native structure develops (Fig. 1b). More
specifically, residues Leu53 and Ile54, which are in
helix III of the native structure and form an integral
part of the hydrophobic core of the native protein,
appear to play little or no role in stabilising the
intermediate state.1,5 By contrast, either or both of
the natively solvent-exposed or partially exposed
residues Tyr55 and Tyr56 in helix III, which are
essential for the inhibitory action of nuclease E
colicin immunity proteins, have been suggested to
form non-native interactions during folding, helping
to anchor the stretch of residues that will ultimately
form helix III onto the three-helix intermediate.2,6–8
Although much less stable than the intermediate
in Im7 folding, an intermediate has been shown to
form transiently during the folding of the Im7
homologue Im9.9 These data suggest that formation
of a three-helical intermediate is a ubiquitous feature
of the folding mechanism of immunity proteins,
with specific side-chain–side-chain interactions in
different proteins stabilising the folding interme-
diates to different extents. This raises the intriguing
question of whether the short nature and low helical
propensity of the sequence comprising the native
helix III, which is highly conserved (83%) across the
family of immunity proteins,10 are responsible forthe development of the three-helical intermediate, or
whether other features of the protein sequence
dictate three-state folding. In order to address this
question, we describe here a series of experiments in
which the sequence of helix III was redesigned to
increase its length and helical propensity through
the insertion of an eight amino acid polyalanine-like
helix without disruption of the native Im7 structure.
The resulting newly extended helix III is predicted to
have a length and a helical propensity that exceed
those of helices I, II and IV. Here, we describe the
design of this variant Im7 and the determination of
its structure using NMR spectroscopy. In parallel, by
analysis of the folding mechanism using ϕ-value
analysis, we provide evidence that suggests an
obligate requirement for folding via a three-helical
Fig. 2. (a) Prediction of the helical propensities of the
four helices in wild-type Im7 and the Im7H3M3 variant
using the prediction algorithm AGADIR.12 Residues in
helices are highlighted in accordancewith Fig. 1a. Residues
in unstructured regions are shown in grey. The helical
propensity of wild-type Im7 helix III is shown in green,
while that of Im7H3M3 is shown in purple. (b) Primary
sequence of residues in helices III and IV and their
sequences in Im7 (top) and Im7H3M3 (bottom). Helix III
(green) and helix IV (yellow) in wild-type Im7 are shown.
Residues predicted to occupy helix III in Im7H3M3 are
shown in purple.
1076 Helix Redesign in Im7 Foldingintermediate, irrespective of the length and helical
propensity of helix III.Results
Construction of a variant of Im7 with a highly
helical helix III
On average, α-helices in native proteins contain 12
residues.11 Helices I, II and IV of Im7, containing 13,
14 and 14 residues, respectively, conform to this
view (Table 1). These three helices have average
helical propensities of ∼8%, 2% and 3%, respective-
ly, as predicted by AGADIR12 (Table 1 and Fig. 2a).
By contrast, helix III of Im7 has only six residues and
no significant helical propensity (Fig. 2a). Of the six
residues that comprise helix III (Thr51, Asp52,
Leu53, Ile54, Tyr55 and Tyr56), Asp52 and Tyr56
are highly solvent exposed, while the remainingTable 2. Kinetic and thermodynamic properties of the foldin
KUI (MUI)
a KIN (mIN)
Im7 196.1±166.7 (4.0±0.1) 253.1±5.6 (0.7±0.0)
Im7H3M3 544.5±92.9 (4.7±0.2) 158.3±4.1 (0.4±0.1)
All rate constants are expressed in s−1, all m-values are expressed in k
were acquired at 10 °C in 50 mM sodium phosphate (pH 7.0) and 0.4
a MUI=(mUI−mIU).
b ΔG UI
o =−RTln(KUI).
c ΔG UN
o =−RTln(KUI(kIN/kNI)).residues are either totally buried or partially buried
in native Im7, leading to stabilisation of the helical
structure of this sequence as the native helix III. In
order to increase the helical propensity of helix III,
we initially considered substituting both Asp52 and
Tyr56 with Ala. According to predictions from
AGADIR,12 however, these substitutions do not
significantly increase the predicted helical propen-
sity of helix III. To increase the helical propensity of
helix III further without perturbing the structure of
the native protein, especially its native hydrophobic
core, we found it necessary to extend the length of
the helix. It has been shown that polyalanine
sequences have a high helical propensity, even in the
absenceof tertiary contacts.13,14 Concatenation of such
a sequence with that of the native helix III was thus
considered to be a possible route towards the redesign
of helix III to a length and a helical propensity
commensurate with those of helices I, II and IV.
Three variants of helix III were designed and
tested. First, the natural sequence of helix III
(TDLIYY) was altered to TALIYA (substituting the
exposed Asp52 and Tyr56 with Ala) without an
increase in predicted helicity. This sequence was then
expanded to contain, in total, an additional eight-
residue helical segment based on the polyalanine
TALIYAAAAAAAA, which increased the average
predicted helicity of the sequence to 7%. Incorpora-
tion of this sequence into Im7, creating variant
Im7H3M1, did not significantly alter the stability
of the native protein compared with that of wild-
type Im7 (ΔGUN
o =−24.1±0.7 kJ mol− 1 and ΔGUNo =
−25.6 ± 0.32 kJ mol− 1, respectively; data not
shown).15 The addition of residues Asn-Pro-Gly at
the C-terminus of the newly incorporated sequence,
which is known to form an efficient C-capping
motif,16 to give an insert sequence of TALIYAAAA-
AAAANP increased the average predicated helical
propensity to 10%, again without significantly alte-
ring the stability of the resulting protein Im7H3M2,
which had a ΔGUN
o of −22.5±0.67 kJ mol− 1 (data not
shown).15
In order to further stabilise the engineered helix, we
introduced a potential salt bridge into the inserted
region as another contributor to α-helix stability.
Such side-chain–side-chain interactions potentially
contribute between 0.4 and 2.0 kJ mol− 1 to the
stability of a protein.17–19 As noted above, Asp52 and
Tyr56 of Im7 are solvent exposed,10 and if the
inserted region adopts the same helical structure,
the residues at position I (originally Tyr56) andg/unfolding of wild-type Im7 and Im7H3M3
KNI (mNI) ΔG UI
o b ΔG UN
o c
0.94±0.1 (−0.5±0.0) −12.4±0.1 −25.6±0.3
4.3±0.3 (−0.7±0.0) −14.8±0.4 −23.3±0.4
J mol−1 M−1 and all free energies are expressed in kJ mol−1. Data
M Na2SO4.
1077Helix Redesign in Im7 Foldingposition V of the insert (Fig. 2b) are predicted to be
solvent exposed. Therefore, the alanine residues at
insert positions I and V were substituted with Glu
and Arg, respectively to create Im7H3M3. As
summarised in Fig. 2b, the redesigned helix III in
Im7H3M3 is expected to contain a C-terminal-
capped polyalanine helix with a salt bridge located
towards its centre. Together, these stabilising
features are predicted to increase the average helicalFig. 3. TFE titration curve of peptides corresponding to diffe
IV (d). The positions of native helices are shown in blue, red
acquired at 10 °C in 50mM sodium phosphate buffer (pH 7.0). I
the spectra in 40% (vol/vol) TFE are shown as dotted lines and t
in continuous black lines. The spectra of helix III in Im7H3M3
TFE (black) (e).propensity of helix III (over all residues) to 14%
(Fig. 2a and Table 1). The variant Im7H3M3 thus
contains a sequence for helix III that has the largest
predicted helical propensity of all four helices in the
protein, while maintaining the key hydrophobic
side chains of Leu53 and Ile54 in the native
hydrophobic core. In addition to the inserted
sequence, Im7H3M3 differs from Im7 in the
sequence linking helices III and IV. The wild-typerent Im7 helices. Helix I (a), helix II (b), helix III (c) and helix
, green and yellow, respectively, in each plot. Data were
n each case, the spectrum in the absence of TFE is coloured,
he spectra at intermediate concentrations of TFE are shown
are shown in 0% (vol/vol) TFE (purple) and 40% (vol/vol)
Fig. 4. Representation of the structure of Im7H3M3,
drawn from the coordinates of 2K0D. The structure of wild-
type Im7 (1AYI)10 is shown in light grey for comparison.
Helices are coloured as follows: helix I, blue; helix II, red;
helix III, purple; helix IV, yellow. The positions of His47
(black) and Trp75 (yellow) in Im7H3M3 are shown, with
their equivalents in Im7 shown in grey. This figure was
drawn using Chimera.42
1078 Helix Redesign in Im7 Foldinginterhelix connection (PSDNRDDS) was substituted
in Im7H3M3 with a linker (GGDGGGP) that is
expected to have a flexibility greater than that of the
native interhelix linker to allow the possibility of the
new polyalanine-rich helix III being accommodated
into the structure without perturbing the docking of
helix IV in the variant Im7 protein. In addition to
the five Gly residues in the inserted linker, aspartic
acid was incorporated to aid solubility.
Im7H3M3 folds into a helical structure, as judged
by far-UV CD (data not shown), with a ΔGUN
o
of −23.3±0.4 kJ mol− 1, determined by equilibrium
denaturation and chevron analysis (see the text
below), similar to the properties of wild-type Im7
(Table 2). This variant was therefore used to study the
importance of the length and helical propensity of
helix III in the folding mechanism of Im7.
CD studies of peptide fragments of Im7 and
Im7H3M3
In order to ascertain whether the polyalanine-rich
sequence of the helix III insert in Im7H3M3 has
increased its helical content, as predicted by its
enhanced helical propensity, we synthesised a pep-
tide equivalent to this sequence and measured its
helical content in aqueous solution and in the
presence of 2,2,2-trifluoroethanol (TFE) using far-
UV CD.20 In parallel, peptides equivalent to the
sequences of helices I, II and IV and of the natural
helix III were also synthesised and studied under
identical conditions (Fig. 3).
The far-UV CD spectrum of the Im7H3M3 helix III
peptide in 0% vol/vol TFE shows a signal typical of
an α-helix with minima at 208 and 222 nm (Fig. 3e),
indicating that the sequence adopts a helical
structure in solution,21 consistent with its design.
The addition of 40% (vol/vol) TFE stabilises the
helix, as observed for other polyalanine helices,20
although propagation of helicity throughout the
peptide is presumably blocked by the presence of
the proline residue towards its C-terminus.22 In
aqueous solution (0% vol/vol TFE), the ellipticity of
helix III peptide from Im7H3M3 results in an
average helical content of 16%, determined from
the magnitude of the signal at 222 nm21 (see
Materials and Methods), that is close to the average
predicted helical propensity of this sequence (∼14%)
(Table 1).12,23,24 As shown in Fig. 2a and Table 1,
peptides with sequences equivalent to those of
helices I, II and IV were predicted to have average
helix propensities of ∼8%, 2% and 3%, respectively.
Each peptide, as measured by TFE titration, under-
went a two-state transition into helical structure, as
indicated by the presence of an isodichroic point in
each titration series at 203 nm (also seeMaterials and
Methods) (Fig. 3a, b and d). These experiments
suggested average helicities of the peptides, deter-
mined from the magnitude of the signal at 222 nm
(see Materials and Methods), that are equivalent to
those of helices I, II and IV (14%, 10% and 11%,
respectively—values significantly greater than those
predicted by AGADIR) (Table 1). The peptide withthe sequence of the natural helix III (Fig. 3c), by
contrast, showed very little helical content in the
absence of TFE and no change upon addition of TFE,
indicating that this small 6-residue sequence
requires tertiary structure formation for it to stabilise
in helical form in native Im7.
Structure of Im7H3M3 and side-chain
interactions
The solution structure of Im7H3M3 was deter-
mined by heteronuclear NMR spectroscopy (see
Materials and Methods). The results revealed a
structure that is remarkably similar to that of wild-
type Im7, with helices I, II and IV adopting native-
like conformations, as reflected by their lengths,
orientations and side-chain arrangements (Fig. 4). As
predicted, helix III has been extended by the
polyalanine insert, entirely consistent with the rede-
sign strategy. Also as predicted, the NMR structure
indicates that both the C-cap motif and the Glu-Arg
salt bridge in helix III are formed; the dihedral angles
are consistent with a C-cap, while the average
distance between the side-chain N atoms in Arg V
and the carboxylate O atom in Glu I is ∼3 Å,
1079Helix Redesign in Im7 Foldingconsistent with the presence of a salt bridge. While a
full description of the structure and dynamics of the
Im7H3M3 variant will be given elsewhere (manu-
script in preparation), it is noteworthy at this point to
highlight the slightly different orientation of Trp75 in
the two structures (Fig. 4), since this residue forms
the fluorophore that is used as a probe for folding
and stability in the studies described below. The
indole ring remains stacked against the side-chain
imidazole of His47 in Im7H3M3, a characteristic
feature of immunity proteins that gives rise to the
low fluorescence intensity of Trp75 in the native
structure.25
Kinetic analysis of Im7H3M3 folding
To determine whether the redesign of the helix III
insert has affected the folding mechanism of Im7, we
analysed the folding and unfolding kinetics of
Im7H3M3 using stopped-flow fluorescence (10 °C,
pH 7.0 and 0.4 M Na2SO4) (see Materials and
Methods). The resulting chevron plot (Fig. 5) shows
that the sequence differences between Im7H3M3 and
wild-type Im7 destabilise the native state slightlyFig. 5. Denaturant dependence of the folding/unfold-
ing rate constants of Im7H3M3, together with the initial
and final fluorescence signals for folding. Top: The
observed rate constants (circles) for the folding/unfolding
of Im7H3M3 plotted as a function of urea concentration.
The data were obtained at pH 7.0, 10 °C and 0.4MNa2SO4.
The continuous line shows the best fit of the data to a
model describing a three-state transition. The broken line
shows the data for wild-type Im7. Bottom: The initial
(triangles) and final (circles) fluorescence signals for the
folding of Im7H3M3. The continuous lines show the initial
and final fluorescence signals fitted simultaneously with
the rate constants. The broken line represents the best fit of
the data obtained for wild-type Im7.(ΔΔGUN
o ∼2.3 kJ mol− 1), with a corresponding in-
crease (4-fold) in the rate constant of unfolding (kNI)
relative to that of wild-type Im7 (Table 2). Remar-
kably, the folding branch of the chevron plot of
Im7H3M3 is unperturbed compared with that of
wild-type Im7, indicating that Im7H3M3 folds via a
three-state mechanism involving a hyperfluorescent
intermediate (Fig. 5). Quantitative analysis of the data
revealed that the stability of the intermediate in
Im7H3M3 is increased relative to the stability of the
intermediate that is transiently populated in wild-
type Im7 (ΔΔGUI
o ∼2.4 kJ mol− 1) (Table 2). The
Im7H3M3 variant exhibits an m-value for the
formation of the intermediate (MUI; MXY represents
the denaturant dependence of the free energy
between X and Y) that is approximately 15% larger
than that of wild-type Im7 (Table 2), consistent with
the increased length of the polypeptide chain and
near-identical native structures of the two proteins.
Accordingly, the m-value for folding from the
unfolded protein to the native state (MUN) for
Im7H3M3 (5.8±0.2 kJ mol− 1 M− 1) is increased
by 10% relative to that observed for wild-type Im7
(5.3±0.1 kJ mol− 1 M− 1). Interestingly, although re-
maining hyperfluorescent, the fluorescence intensity
of the intermediate formed during the folding of
Im7H3M3 is reduced comparedwith the intermediate
formed in the folding of wild-type Im7. Further expe-
riments showed that this results, in part, from the
substitution of Tyr56 with Ala, which must subtly
alter the environment of Trp75 in the intermediate
ensemble such that its fluorescence quantum yield is
reduced.15
The small differences observed in the folding
behaviour of Im7H3M3 compared with that of wild-
type Im7 is surprising given that 9 native residues
have been removed and 16 non-native residues have
been inserted, including a region predicted bypeptide
studies to be significantly helical even in the
denatured state (Fig. 3e). It has previously been
shown that the insertion of only 4 alanine residues
into a loop region after helix VIII of T4 lysozyme
destabilises its native state by ∼25 kJ mol− 1, with a
similar result being observed for the insertion of 3
alanine residues into a loop region after helix III in the
same protein.26 T4 lysozyme is approximately twice
the size of Im7. It is striking, therefore, that the smaller
Im7 tolerates the insertion without substantial per-
turbation of native-state stability (ΔΔGUN
o =2.3 kJ
mol− 1) (Table 2). One possible explanation for the
tolerance of Im7 for the polyalanine insertion is that
the glycine linker allows the native structure to
accommodate the extended helix III without causing
strain on helix IV. Of particular interest is the sta-
bilisation of the intermediate ensemble in Im7H3M3
compared with the intermediate of wild-type Im7
(ΔΔGUI
o =2.5 kJ mol− 1). Work performed on an
intermediate ensemble of Im7 trapped at equilibrium
by the mutation of Leu53 and Ile54 to alanine5 shows
that this variant displays an increased exposed
hydrophobic surface area relative to the native state.
Therefore, it is plausible that the polyalanine helix of
Im7H3M3 helps protect this hydrophobic surface
1080 Helix Redesign in Im7 Foldingarea from solvent in the intermediate ensemble, as
was observed for the insertion variant L164-[AAAA]
of T4 lysozyme.26
ϕ-Value analysis
In order to determine inmore detail the effect of the
sequence differences between Im7 and Im7H3M3 on
the folding mechanism of Im7, we created a number
of variants of Im7H3M3 (Table 3). Hydrophobic
substitutions were made at residues in the core of the
protein that have previously been shown to play a
key role in the folding mechanism of Im7,1,2 so that
the formation of tertiary structure contacts during
folding could be investigated. In addition, to probe
the formation of secondary structure, we made a
series of alanine-to-glycine substitutions at solvent-
exposed sites that included residues in all four
helices. The folding and unfolding kinetics of all
variants were then assessed using stopped-flow
fluorescence, and the results were collated as a series
of ϕ-values. Altogether, 24 variants that span the
squence of Im7H3M3 were studied. Hydrophobic
substitutions made in the centre of helix I (V16A and
L19A) show that these residues, which are buried in
the native state, stabilise the intermediate-state and
transition-state ensembles in both wild-type Im7 and
Im7H3M3, resulting in ϕI and ϕTS values of N0.6 for
both Im7HM3 and wild-type Im7 (Fig. 6a and b and
Table 4). These side chains, therefore, are buried
early in the folding of both wild-type Im7 and
Im7H3M3.Table 3. Kinetic and thermodynamic parameters for the fold
Protein Location in native structure KUI (MUI)
Im7H3M3 — 544.5±92.9 (4.7±0.2) 158
A13G Helix I (exposed) 155.4±31.4 (4.7±0.2) 174.
V16A Helix I (buried) 29.2±5.2 (4.7±0.2) 2
L19A Helix I (buried) 24.7±3.0 (4.7±0.2) 259
K24A Helix I (exposed) 333.3±96.3 (4.7±0.2) 142
A24G Helix I (exposed) 368.1±37.0 (4.7±0.2) 157
V33A Helix II (exposed) 874.6±68.8 (4.7±0.2) 143
D35A Helix II (exposed) 3092.8±223.2 (4.7±0.2) 85.
A35G Helix II (exposed) 1818.2±165.3 (4.7±0.2) 99
L37A Helix II (buried) 35.7±10.5 (4.7±0.2) 382.
E39A Helix II (exposed) 1734±210 (4.7±0.2) 134
A39G Helix II (exposed) 1851±171 (4.7±0.2) 63
F41L Helix II (buried) 170.5±32.0 (4.7±0.2) 421.
V42A Helix II (partially buried) 57.8±17.8 (4.7±0.2) 585.
T51S Helix III (buried) 290.1±28.1 (4.7±0.2) 204
A52G Helix III (exposed) 288.5±66.6 (4.7±0.2) 177
L53A Helix III (buried)a 163.9±59.1 (4.7±0.2)
I54V Helix III (buried) 222.2±37.9 (4.7±0.2) 225.
AIIG Helix III (exposed) 238.1±30.2 (4.7±0.2) 35
AVIG Helix III (exposed) 137.0±16.3 (4.7±0.2) 221
V69A Helix IV (buried) 219.0±16.0 (4.7±0.2) 192
K70A Helix IV (exposed) 576.9±36.6 (4.7±0.2) 148
A70G Helix IV (exposed) 87.5±12.7 (4.7±0.2) 240.
A77G Helix IV (exposed) 140.8±23.1 (4.7±0.2) 13
A78G Helix IV (exposed) 91.7±14.6 (4.7±0.2) 123
All rate constants are expressed in s−1, all m-values are expressed in k
were acquired at 10 °C in 50 mM sodium phosphate (pH 7.0) and 0.4
a L53A folds predominantly (N95%) to an intermediate state. The
denaturant were fitted to a two-state transition, yielding kUI (450.7±2
were calculated. Equilibrium studies confirmed that these parameters
and MUI=4.7±0.5 kJ mol
−1 M−1, determined by equilibrium denaturaWhen considered as a whole, the variants of
Im7H3M3 in helix II that were examined by muta-
tional analysis also showedproperties similar to those
obtained for Im7 (Fig. 6c and d). L37A, F41L and
V42A show high ϕI values in Im7H3M3 (1.02±0.0,
1.08±0.12 and 1.66±0.2, respectively) that are re-
duced in the transition-state ensemble (0.69±0.00,
0.16±0.12 and 0.69±0.01, respectively). Despite the
similarity in ϕ-values for residues in helices I and II,
some subtle structural reorganisation of the interme-
diate ensemble in Im7H3M3 may have occurred
relative to that of Im7, however, as reflected in the
increased ϕ-values of V16A, L19A (Fig. 6a and b)
L37A and V42A in Im7H3M3 relative to those in Im7
(Fig. 6c and d and Table 4) and consistent with the
altered fluorescence properties of this species (Fig. 5).
Three residues were mutated in helix IV of
Im7H3M3. Two residues (A77G and A78G) exhibit
ϕI and ϕTS values similar to those of the corres-
ponding residues of Im7 (Fig. 6g and h). Data
obtained for the variant V69A at the N-terminus of
helix IV indicate that this region of the protein does
not make substantial stabilising contacts in the
intermediate and transition states of wild-type Im7,
as shown by the low ϕ-values of this variant. Desta-
bilisation of native Im7H3M3 by this substitution,
however, results in a ΔΔGUN
o of b2.5 kJ mol− 1, a
value too small to allow an accurate ϕ-value to
be calculated for this site in the redesigned protein
(Fig. 6g and h).27 Taken together, the data suggest
that helix IV is at least partly formed in the
intermediate ensemble and that the insertion of theing/unfolding kinetics of Im7H3M3 variants
KIN (mIN) KNI (mNI) ΔG UI
o ΔG UN
o
.3±4.1 (0.4±0.1) 4.26±0.3 (−0.7±0.0) −14.8±0.4 −23.3±0.4
6±12.9 (0.5±0.2) 2.4±0.14 (−0.9±0.0) −11.9±0.5 −21.9±0.5
16±8.8 (0.3±0.1) 7.1±0.19 (−0.7±0.0) −7.9±0.4 −15.9±0.4
±56.13 (1.8±1.3) 24.5±0.51 (−1±0.0) −7.5±0.9 −13.1±0.9
.3±6.7 (0.2±0.1) 5.99±0.56 (−0.7±0.0) −13.7±0.7 −21.1±0.7
.1±6.3 (0.4±0.1) 7.89±0.27 (−0.7±0.0) −13.9±0.2 −20.9±0.3
.8±3.9 (0.6±0.0) 4.36±0.1 (−0.9±0.0) −15.9±0.2 −24.1±0.2
2±2.19 (0.3±0.03) 4.19±0.28 (−0.7±0.0) −18.9±0.2 −25.9±0.2
.6±4.6 (0.17±0.06) 7.5±0.58 (−0.6±0.0) −17.6±0.2 −23.7±0.3
0±27.4 (0.7±0.3) 9.7±0.4 (−1.5±0.0) −8.4±0.7 −17.0±0.7
.7±7.4 (0.55±0.08) 8.79±0.68 (−0.5±0.0) −17.5±0.3 −24.0±0.4
.0±2.3 (0.49±0.05) 20.4±0.66 (−0.4±0.0) −17.7±0.2 −20.4±0.3
7±26.7 (0.1±0.1) 10.3±0.55 (−0.7±0.0) −12.1±0.4 −20.8±0.5
3±41.8 (0.8±0.2) 6.45±0.68 (−0.9±0.0) −9.5±0.7 −20.1±0.8
.2±9.0 (0.5±0.0) 4.62±0.24 (−1±0.0) −13.4±0.2 −22.3±0.3
.5±2.9 (0.5±0.0) 5.3±0.3 (−0.9±0.0) −13.3±0.6 −21.6±0.6
− − −17.4±2.0 −
7±14.1 (0.5±0.1) 4.80±0.19 (−1.3±0.0) −12.7±0.4 −21.8±0.4
5±15.1 (1.2±0.1) 11.6±0.28 (−1±0.0) −12.9±0.3 −20.9±0.3
.4±9.5 (0.3±0.1) 5.9±0.18 (−0.7±0.0) −11.6±0.3 −20.1±0.3
.6±6.6 (0.3±0.1) 5.2±0.17 (−0.9±0.0) −12.7±0.2 −21.2±0.2
.9±4.6 (0.2±0.05) 6.7±0.3 (−0.6±0.0) −14.9±0.2 −22.3±0.2
3±11.9 (0.7±0.1) 6.0±0.18 (−0.8±0.0) −10.5±0.3 −19.2±0.4
2.±7.2 (0.9±0.1) 8.8±0.28 (−0.6±0.0) −11.6±0.4 −18.0±0.4
.3±6.2 (0.4±0.1) 9.2±0.2 (−0.7±0.0) −10.6±0.4 −16.7±0.4
J mol−1 M−1 and all free energies are expressed in kJ mol−1. Data
M Na2SO4. Errors were calculated as described in Friel et al.
2
rates of folding of this variant versus the rates of folding of the
5.3 s−1) and kIU (10.3±0.7 s
−1) from which ΔGUI
o (and MUI) values
equate to those determined kinetically (ΔGUI
o =−17.4±2.0 kJ mol−1
tion monitored by far-UV CD at 222 nm).
Table 4. ϕ-Values for Im7H3M3 variants and variants of
wild-type Im7
Im7H3M3 ΦI Im7H3M3 ΦTS Im7 ΦI Im7 ΦTS
A13G ND ND 1.29±0.13 1.25±0.12
V16A 0.94±0.03 0.84±0.02 0.69±0.03 0.77±0.03
L19A 0.71±0.09 0.60±0.12 0.43±0.08 0.34±0.08
A35G 0.55±0.09 0.39±0.09 NA NA
L37A 1.02±0.00 0.69±0.00 0.63±0.08 0.51±0.05
A39G −0.06±0.10 0.48±0.06 NA NA
F41L 1.08±0.12 0.16±0.12 1.37±0.09 0.25±0.02
V42A 1.66±0.20 0.69±0.01 0.41±0.05 0.13±0.06
T51S ND ND 0.11±0.05 0.09±0.05
I54V ND ND 0.08±0.03 0.12±0.03
AVIG 1.0±0.07 0.75±0.06 − −
V69A ND ND 0.18±0.1 0.12±0.11
A70G 1.45±0.1 1.09±0.05 NA NA
A77G 0.60±0.05 0.68±0.04 0.81±0.04 0.85±0.04
A78G 0.64±0.04 0.73±0.03 0.61±0.05 0.77±0.04
Data for wild-type Im7 were taken from Capaldi et al.,1 with
values recalculated from raw data as described by Friel et al.2
NA=data are not available since equivalent mutations were not
created in the background of wild-type Im7.
ND=not determined since ΔΔG UN
o b2.5 kJ mol−1.27
Fig. 6. Comparison of ϕI and
ϕTS for Im7 (grey) and Im7H3M3
(coloured). (a and b) Helix I, (c and
d) helix II, (e and f) helix III and
(g and h) helix IV. ND (not det-
ermined): residues that display
ΔΔGUN
o b2.5 kJ mol− 1 precluding
the determination of a ϕ-value.27
1081Helix Redesign in Im7 Foldingextended helix III sequence into Im7 has only very
minor effects on the structure of the intermediate
ensemble, the rate-limiting transition-state ensemble
and the native state in this region.
Mutation of residues in helix III in Im7H3M3
exhibit the largest differences in stability relative
to substitutions in this region in wild-type Im7. The
ϕ-values for residues mutated in helix III for Im7
suggest that the side chains of Thr51 and Ile54 make
few stabilising contacts in the intermediate-state and
transition-state ensembles (ϕI and ϕTS values for all
residues are b0.15; Table 4), despite destabilising the
native state by ∼11 kJ mol− 1 for I54V (Table 3
and Fig. 6e and f). However, the Im7H3M3 variant
I54V shows a result very different from that of Im7
I54V, insofar as the native state is only marginally
destabilised by this substitution (ΔΔGUN
o ∼1.5 kJ
mol− 1 for I54V in Im7H3M3 compared with 11 kJ
mol− 1 for this substitution in wild-type Im7),1 while
the stability of the intermediate ensemble is affected
to approximately the same degree (ΔΔGUI
o ∼2.1 kJ
mol−1) for both proteins (Table 4). The small ΔΔGUN
o
for this substitution in Im7H3M3 prevents the
1082 Helix Redesign in Im7 Foldingaccurate determination of a ϕ-value,27 but the diffe-
rent effect of this mutation on the native-state stabi-
lity of Im7H3M3 and Im7 is clear. Thus, the sequence
differences between Im7 and Im7H3M3 appear to
have negated the need for the side chain of Ile54 to be
present in order to stabilise the native state.
In contrast with the Im7H3M3 I54V variant, the
L53A variant of Im7H3M3 responds similarly to
mutation as the L53A variant of Im7;1 in both cases,
the truncation of residue 53 destabilises the native
state to such an extent that the intermediate en-
semble becomes the predominantly populated spe-
cies at equilibrium. The observed rate constant of
folding for the Im7H3M3 variant L53A is signifi-
cantly faster (450 s− 1) than that for Im7H3M3
(158 s− 1), suggesting that the observed rate constant
for the folding of the Im7H3M3 L53A variant moni-
tors folding to the intermediate ensemble. In agree-
ment with this, the folded state of the Im7H3M3
L53A variant in the absence of denaturant is more
fluorescent than the denatured state and unfolds
with an equilibrium free energy of 17.4±2.0 kJ mol− 1,
consistent with the ΔGUI
o for Im7H3M3 (data not
shown). Despite the fact that ϕI and ϕTS values
could not be determined for the substitutions made
in helix III of Im7H3M3, the similarity in the res-
ponses of the intermediate ensemble to mutations at
residues 53 and 54 suggests that the presence of an
extended helix III has not substantially altered the
folding mechanism of Im7 in that the newly de-
signed protein still folds to a stable native structure
via a three-state transition, involving a hyperfluor-
escent intermediate with a three-helix core, as has
been described for the wild-type protein.1,2Discussion
The data presented here indicate that the insertion
of a polyalanine helix C-terminal to helix III in Im7
has a negligible effect on the foldingmechanismof the
protein. The variants designed to probe differences
between the folding mechanisms of Im7 and
Im7H3M3 exhibit similar ϕ-values for all of the
residues examined (Fig. 6), consistent with the
insertion of a large and highly helical sequence in
place of helix III having little effect on the folding
mechanism. Despite the wholesale similarities in
ϕ-values, several residues in the natural helix III
sequence displayed extensive differences in their res-
ponse tomutation in the native state of the Im7H3M3
compared with Im7. The most striking difference
observed was for the mutation I54V, which destabi-
lises the native state of Im7 by ∼11 kJ mol− 1 yet
destabilises Im7H3M3byonly 1.5 kJmol− 1. Although
surprising, this result is similar to that observed for
the T4 lysozyme variant L133A, where the substitu-
tion had a large destabilising effect on the native state
(ΔΔGUN
o ∼20 kJ mol− 1) but, when included as part of
an 8-residue alanine helix, had a reduced destabilis-
ing effect on the native state (ΔΔGUN
o ∼10 kJ mol− 1).
The results observed for the Im7H3M3 variant of Im7
suggest, therefore, that insertion of the polyalaninesequence allows compensation for the removal of the
branched side chain of Ile54 such that the native
protein is substantially less sensitive to mutation at
this site, possibly by structural reorganisation of the
core of the native structure upon truncation of the
isoleucine side chain. As a consequence in the
Im7H3M3 variant, the native state can still be pre-
ferentially populated despite truncation of this key
residue in the native hydrophobic core.
The goal of this work was to determine whether
helix III was the last helix to form during the folding
of Im7 because it is the shortest of the four helices and
has no significant helical propensity, or whether
other features of the protein sequence dictate the
formation of the three-helix intermediate en route to
the native state. The data presented here indicate that
the formation of a three-helix intermediate stabilised
by both native and non-native interactions is an
integral feature of the foldingmechanism of Im7 and
that folding via a three-state mechanism does not
result from the short length and low helical
propensity of the sequence of the native helix III.
The results reveal that the helical propensity of helix
III is not a key driver for the folding mechanism of
Im7 and that formation of the full helix III requires
docking onto the appropriate surface of the non-
native three-helix bundle, where side-chain–side-
chain interactions stabilise the sequence and allow
the formation of helical structure. Thus, the three-
helix bundle core can be considered as a folding
template for helix III. The results add weight to the
growing body of information on the folding mech-
anism of Im7, showing that folding via a three-helical
intermediate is an obligate feature of the folding me-
chanism of this family of proteins. Indeed, a recent
ϕ-value analysis of the folding of Im7, combined
with molecular dynamics simulations, has provided
insights intowhy a three-helical intermediatemay be
a ubiquitous feature of the rugged energy landscape
of this family of proteins, in that functional residues
located within helices II and III, particularly involv-
ing Tyr55, appear to form stabilising non-native
contacts in the intermediate ensemble that occlude
the binding site for helix III.2 The data presented here
show that even when this region contains a
preformed helical structure in the denatured state,
helix III cannot compete with the rapid non-native
docking of aromatic and hydrophobic residues early
in Im7 folding such that a mechanism involving the
canonical three-helical intermediate is preserved.Materials and Methods
Mutagenesis and protein purification
Mutagenesis was carried out with the QuikChange site-
directed mutagenesis kit (Stratagene) using the Im7 gene
in pTrc99A as template.1 All proteins were expressed as
His-tagged versions and were purified to homogeneity, as
described previously.1 Expression and purification of iso-
topically labelled Im7H3M3 were carried out as described
previously for Im7.6
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In order to construct an Im7H3M3 megaprimer, we
performed PCR.28 Megaprimer PCR requires the use of
three primers: two are non-mutagenic and contain either
the NcoI restriction site or the HindIII restriction site that
is found at the 5′ and 3′ ends of the Im7 gene, respectively,
and the third is an internal mutagenic primer. Due to
large-scale changes, a second extension primer was used
in addition to the third internal mutagenic primer. In the
first round of megaprimer PCR, the Im7 template DNA
was used to produce the necessary extension product for
the next round of PCR. The megaprimer was separated
from the rest of the products of PCR by agarose gel elec-
trophoresis and purified from the gel using the QIAquick
Gel Extraction Kit (Qiagen, UK), in accordance with the
manufacturer's instructions. In the second round, the
newly extended Im7 template DNA was used in a second
PCR to produce a further extended gene. A final, third
round of PCR was performed, producing the required
mutant gene, with short flanking sequences that contain
relevant restriction sites for ligation into the expression
vector pTrc99a. The full-length mutant gene was isolated
by agarose gel electrophoresis and purified using a
QIAquick Gel Extraction Kit. Pure mutated DNA was
digested with appropriate restriction endonucleases and
ligated into the plasmid pTrc99a. The DNA encoding the
mutant gene was sequenced to ensure that it contained the
desired change and no other.Analysis of peptide fragments of Im7 in TFE
Peptides were purchased from Peptide Protein Research
(Fareham, UK) as 50% pure samples. Crude lyophilised
peptide was purified to N95% by reverse-phase HPLC
using a C18 column (Dionex, USA). A stock peptide
solution was prepared by dissolving 1.5 mg ml− 1 of each
peptide in buffer (50 mM sodium phosphate, pH 7.0), and
its concentration was determined using the extinction
coefficient.29 The sequence used to measure the helical
propensity of helix II lacked a chromophore; therefore,
Gly-Tyr was added to the C-terminus of the sequence to
allow its concentration to be determined.22 Each peptide
stock solution was then diluted 10-fold into a solution
containing trifluoroethanol (0–80% volume TFE/total vo-
lume). All peptide concentrations were within the range
20–80 μM.13 In order to assess the effect of concentration
on the peptide conformation, we made a second stock
solution independently (concentration N200 μM) and also
measured it (data not shown). The molar ellipticity of all
peptides was shown to be concentration independent over
the range 20–200 μM. All peptides were soluble in the
buffer used at all TFE concentrations. The samples were
incubated overnight at 10 °C before analysis by CD (using
a 1-mm pathlength cuvette; Hellma, UK). Sixteen scans
were collected to improve the signal-to-noise ratio. All CD
spectra were corrected for the signal of the buffer alone.
Peptides equivalent to helices I, II and IV undergo a two-
state transition between less helical forms and fully helical
forms, as shown by the presence of an isodichroic point at
203 nm (Fig. 3). Consistent with this, analysis of the
intensity of the signals at 190–195, 195–210 and 222 nm as
a function of TFE concentration30 also indicated a two-
state transition between coil and helix for these peptides
(data not shown).
The observed ellipticity at 222 nm (θ222) in 0% TFE was
used to determine the fraction helicity of each peptide
using Eq. (1).31,32 In this analysis, the ellipticity at 222 nmis assumed to be linearly related to the mean helix content
of a peptide:
fH = u222  uCð Þ= uH  uCð Þ ð1Þ
where θC is the ellipticity of a random coil, and θH is the
ellipticity of a fully formed helix. Both parameters are
temperature dependent and derived from Eqs. (2) and (3),
respectively:
uC = 2; 220 53 temp-Cð Þ ð2Þ
uH = 44; 000 + 250 temp-Cð Þð Þ 1 3=Nrð Þð Þ ð3Þ
where the values 2220 and −44,000 cm2 deg dmol−1
peptide bond− 1 are the ellipticities of the random coil and
helix at 0 °C, respectively. The value −44,000 cm2 deg
dmol− 1 peptide bond− 1 is the ellipticity of an infinite
length helix and, therefore, has a length correction factor
included (1–3/Nr), where Nr is the number of residues in
the peptide chain.
Kinetic data collection and analysis
All kinetic experiments were performed using an
Applied Photophysics SX18.MV stopped-flow fluorime-
ter, as previously described.1 The temperature was
maintained at 10±0.1 °C using a Neslab-RTE300 circu-
lating water bath. Fluorescence was excited at 280 nm
with a 10-nm bandwidth, and a longpass filter was used
to monitor the emission fluorescence at N320 nm.
Refolding experiments were performed by a 1:10 dilution
of unfolded protein (initial concentration, 50 μM) in
unfolding buffer (50 mM sodium phosphate, 0.4 M
Na2SO4, 1 mM ethylenediaminetetraacetic acid and 8 M
urea, pH 7.0) into a buffered urea solution to yield a final
urea concentration within the range 0.75–7.75 M (in 0.25-
M increments). Unfolding experiments were performed
by a 1:10 dilution of protein (initial concentration, 50 μM)
in refolding buffer (50 mM sodium phosphate, 0.4 M
Na2SO4 and 1 mM ethylenediaminetetraacetic acid,
pH 7.0) into a buffered urea solution to yield final urea
concentrations within the range 3.0–7.75 M in 0.25-M
increments. The resultant transients were fitted to a single
exponential using the manufacturer's software (Spectraki-
netic Workstation, v4.47; Applied Photophysics). The rate
constants determined at each concentration were used to
fit the resulting data to a three-state mechanism
U⇌
kUI
kIU
I⇌
kIN
kNI
N ðScheme 1Þ
whereU, I andN are the unfolded, intermediate and native
states, respectively, and kXY is the rate constant for folding
between X and Y. Previous analysis of the folding of Im7
using ultrarapidmixing has shown the folding of the wild-
type protein to be entirely consistent with such a model.2,3
The data for each protein measured were fitted using
Igor 5.0 (Wavemetrics).2 When fitting data to Scheme 1,
the formation of the intermediate was assumed to occur
rapidly as a preequilibrium step. kUI was fixed at 3000 s
−1
for Im7 and all Im7H3M3 variants. The stability of the
intermediate was then determined by allowing kIU to vary.
The macroscopic M-value MUI was fixed at 4.7 kJ mol
−1
M− 1 (the value determined for the wild-type Im7H3M3)
and assumed to be identical for each variant. The
microscopic m-values mIN and mNI (mXY represents the
denaturant dependence of the natural logarithm of the
rate constant kXY) were allowed to vary freely.
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ϕI and ϕTS for the 24 variants of Im7H3M3 at pH 7.0 and
10 °C were determined by an analysis of folding and
unfolding kinetics as a function of urea concentration.
With only a single exception (L53A), folding was three
state, as demonstrated by a kinetic rollover in the
logarithm of the folding rate constant versus denaturant
concentration at low denaturant concentration and by the
presence of an increase in fluorescence signal in the dead
time of the stopped-flow experiment (∼2.5 ms). Previous
studies have shown that the only mechanism that can
describe all the observed folding and unfolding data for
Im7 is a three-state mechanism with an on-pathway
intermediate.2,3 The chevron plots for Im7 and each
variant, together with their initial and final fluorescence
signals, were fitted to Scheme 1. It was assumed that the
mutation altered the equilibrium stability of the interme-
diate and/or the folding/unfolding rate constants, while
MUI was assumed to be constant. Analysis of the kinetics
of folding/unfolding showed no dependence on protein
concentration (0.5–50 μM).
ϕTS-values were calculated according to:
ATS =
DDGWTVARUTS
DDGWTVARUN
where ΔΔGU–TS
WT–VAR is the change in free energy of the
transition state, referenced to the unfolded state, and is the
difference in free energy between the native state and the
unfolded state of the wild-type (WT) and variant (VAR)
proteins, respectively.
Similarly, ϕI was calculated according to:
AI =
DDGWTVARUI
DDGWTVARUN
Errors on all parameters were propagatedmathematically.
NMR spectroscopy
NMR spectra for the structure determination of
Im7H3M3 were collected at 25 °C on Varian INOVA 500-
and 600-MHz spectrometers at the University of East
Anglia and on a Varian 900-MHz spectrometer at the
Henry Wellcome Building NMR facility (University of
Birmingham). A series of three-dimensional spectra [CBCA
(CO)NH, HNCACB, HNCO, HCCH total correlated
spectroscopy, H(CCO)NH, C(CO)NH, 1H–1H–15N nuclear
Overhauser enhancement spectroscopy (NOESY) hetero-
nuclear single quantum coherence (HSQC) and 1H–1H–13C
NOESY-HSQC] was collected for complete assignments
and nuclear Overhauser enhancement measurement. All
NMR data were processed using NMRPipe33 and analysed
using NMR View.34 The structure was determined with the
software package ATNOS–CANDID–CYANA35–37 and
refined in explicit solvent with Xplor-NIH38,39 from nuclear
Overhauser enhancements obtained from 1H–1H–13C and
1H–1H–15N NOESY-HSQC spectra. None of the final
structures contain violations of dihedral angle restraints
larger than 10° or violations of distance restraints greater
than 0.5 Å. For the final ensemble of 30 structures,
the RMSD calculated over residues 2–94 is 0.68±0.13
and 0.94±0.09 Å for backbone and all heavy atoms, respec-
tively. The Ramachandran plot for the ensemble of 30
structures determined with PROCHECK40 had 91.2% of
residues in core regions, 8.4% of residues in allowed regionsand 0.4% of residues in disallowed regions. Summary
WHAT IF statistics41 are shown below. These statistics
provide an overall summary of the quality of the structure
as compared with current reliable structures. Structure
Z-scores show a number of constraint-independent quality
indicators. RMS Z-scores mostly give an impression of how
well the model conforms to common refinement constraint
values. The standard deviation shows variation over
models in the ensemble, where appropriate.
Structure Z-scores: first-generation packing quality,
−0.167±0.174; second-generation packing quality, −0.772±
0.199; Ramachandran plot appearance, −2.835±0.416;
χ1/χ2 rotamer normality, −4.068±−0.464; backbone
conformation, −1.464±0.642.
RMS Z-scores: bond lengths, 1.178±−0.009; bond angles,
0.555±0.014; ω angle restraints, 0.115±0.006; side-chain
planarity, 0.945±0.137; improper dihedral distribution,
0.897±−0.090; inside/outside distribution, 0.988±0.011.
Accession numbers
Coordinates for the structure of Im7H3M3 have been
deposited in the Protein Data Bank with accession number
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